An analysis of NRG/RTOG 0815 found Decipher predicted distant metastasis risk and identified patients with greater benefit from short-term ADT.
|Videos|August 3, 2021
When is the right time for genetic testing in prostate cancer?
Advertisement
Samantha E. Greenberg, MS, MPH, CGC, a genetic counselor at the Huntsman Cancer Institute, on when to discuss genetic testing with prostate cancer patients.
Advertisement
Related to this article
Using PSMA-PET imaging and genomic testing to obtain better information earlier in the disease course changes what clinicians can do with diagnosis and treatment planning.
Advertisement
Advertisement
Trending on Urology Times
1
Avoiding False Positives on Prostate Cancer PSMA PET Scans
2
2026 AUA/SUO NMIBC guideline: Key updates for clinical practice
3
Decipher may help identify ADT benefit in intermediate-risk prostate cancer
4
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
5